Opsonization of HIV with complement enhances infection of dendritic cells and viral transfer to CD4 T cells in a CR3 and DC-SIGN-dependent manner

Journal of Immunology

Volumn 178, Issue 2, 2007, Pages 1086-1095

  Bouhlal, Hicham ^a,d   Chomont, Nicolas ^b   Réquena, Mary ^a   Nasreddine, Nadine ^a   Saidi, Héla ^a   Legoff, Jérôme ^a   Kazatchkine, Michel D ^c   Bélec, Laurent ^a   Hocini, Hakim ^a  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b UNIVERSITY OF MONTREAL   (Canada)

^c INSERM   (France)

^d CENTRE DE RECHERCHE DES CORDELIERS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CD209 ANTIGEN; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR4; COMPLEMENT COMPONENT C3 RECEPTOR; COMPLEMENT RECEPTOR; RANTES; STROMAL CELL DERIVED FACTOR 1;

ARTICLE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; DENDRITIC CELL; HELA CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE; MONOCYTE; NONHUMAN; OPSONIZATION; PRIORITY JOURNAL; PROTEIN FUNCTION; VIRUS ADSORPTION; VIRUS CELL INTERACTION; VIRUS INACTIVATION; VIRUS TRANSMISSION;

EID: 33846203404     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.178.2.1086     Document Type: Article

References (37)

1. Spira, A. I., P. A. Marx, B. K. Patterson, J. Mahoney, R. A. Koup, S. M. Wolinsky, and D. D. Ho. 1996. Cellular targets of infection and route of viral dissemination after an intravaginal inoculation of simian immunodeficiency virus into rhesus macaques. J. Exp. Med. 183: 215-225.
2. Van de Perre, P. 1999. Transmission of human immunodeficiency virus type 1 through breast-feeding: how can it be prevented? J. Infect. Dis. 179(Suppl 3): S405-S407.
3. Sayegh, R. A., X. J. Tao, J. T. Awwad, and K. B. Isaacson. 1996. Localization of the expression of complement component 3 in the human endometrium by in situ hybridization. J. Clin. Endocrinol. Metab. 81: 1641-1649.
4. Moon, R., T. A. Pritts, A. A. Parikh, J. E. Fischer, A. L. Salzman, M. Ryan, H. R. Wong, and P. O. Hasselgren. 1999. Stress response decreases the interleukin-1β-induced production of complement component C3 in human intestinal epithelial cells. Clin. Sci. 97: 331-337.
5. Rahimi, A., H. Sepehri, J. Pakravesh, and K. Bahar. 1999. Quantification of C3 and C4 in infertile men with antisperm antibody in their seminal plasma. Am. J. Reprod. Immunol. 41: 330-336.
6. Thieblemont, N., N. Haeffner-Cavaillon, A. Ledur, J. L'Age-Stehr, H. W. Ziegler-Heitbrock, and M. D. Kazatchkine. 1993. CR1 (CD35) and CR3 (CD11b/CD18) mediate infection of human monocytes and monocytic cell lines with complement-opsonized HIV independently of CD4. Clin. Exp. Immunol. 92: 106-113.
7. Delibrias, C. C., E. M. Fischer, and M. D. Kazatchkine. 2000. The enhancing role of complement in human immunodeficiency virus infection: soluble recombinant CR1 (CD35) inhibits complement-mediated enhancement of infection of a CD4-positive T-cell line with human immunodeficiency virus-1. Scand. J. Immunol. 51: 526-529.
8. Stoiber, H., I. Frank, M. Spruth, M. Schwendinger, B. Mullauer, J. M. Windisch, R. Schneider, H. Katinger, I. Ando, and M. P. Dierich. 1997. Inhibition of HIV-1 infection in vitro by monoclonal antibodies to the complement receptor type 3 (CR3): an accessory role for CR3 during virus entry? Mol. Immunol. 34: 855-863.
9. Bouhlal, H., J. Galon, M. D. Kazatchkine, W.-H. Fridman, C. Sautès-Fridman, and N. Haeffner-Cavaillon. 2001. Soluble CD16 inhibits CR3 (CD11b/CD18)-mediated infection of monocytes/macrophages by opsonized primary R5 HIV-1. J. Immunol. 166: 3377-3383.
10. Bouhlal, H., N. Chomont, N. Haeffner-Cavaillon, M. D. Kazatchkine, L. Bélec, and H. Hocini. 2002. Opsonization of HIV-1 by semen complement enhances infection of human epithelial cells. J. Immunol. 169: 3301-3306.
11. Bajtay, Z., C. Speth, A. Erdei, and M. P. Dierich. 2004. Cutting edge: productive HIV-1 infection of dendritic cells via complement receptor type 3 (CR3, CD11b/CD18). J. Immunol. 173: 4775-4778.
12. Lore, K., and M. Larsson. 2003. The role of dendritic cells in the pathogenesis of HIV-1 infection. APMIS 111: 776-788.
13. Teleshova, N., I. Frank, and M. Pope. 2003. Immunodeficiency virus exploitation of dendritic cells in the early steps of infection. J. Leukocyte Biol. 74: 683-690.
14. Ayehunie, S,, E. A. Garcia-Zepeda, J. A. Hoxie, R. Horuk, T. S. Kupper, A. D. Luster, and R. M. Ruprecht. 1997. Human immunodeficiency virus-1 entry into purified blood dendritic cells through CC and CXC chemokine coreceptors. Blood 90: 1379-1386.
15. Delgado, E., V. Finkel, M. Baggiolini, C. R. Mackay, R. M. Steinman, and A. Granelli-Piperao. 1998. Mature dendritic cells respond to SDF-1, but not to several β-chemokines. Immunobiology 198: 490-500.
16. Zaitseva, M., A. Blauvelt, S. Lee, C. K. Lapham, V. Klaus-Kovtun, H. Mostowski, J. Manischewitz, and H. Golding. 1997. Expression and function of CCR5 and CXCR4 on human Langerhans cells and macrophages: implications for HIV primary infection. Nat. Med. 3: 1369-1375.
17. Steinman, R. M., A. Granelli-Piperao, M. Pope, C. Trumpfheller, R. Ignatius, G. Arrode, P. Racz, and K. Tenner-Racz. 2003. The interaction of immunodeficiency viruses with dendritic cells. Curr. Top. Microbiol. Immunol. 276: 1-30.
18. Cameron, P., M. Pope, A. Granelli-Piperao, and R. M. Steinman. 1996. Dendritic cells and the replication of HIV-1. J. Leukocyte Biol. 59: 158-171.
19. Canque, B., M. Rosenzwajg, S. Camus, M. Yagello, M. L. Bonnet, M. Guigon, and J. C. Gluckman. 1996. The effect of in vitro human immunodeficiency virus infection on dendritic-cell differentiation and function. Blood 88: 4215-4228.
20. Nobile, C., C. Petit, A. Moris, K. Skrabal, J. P. Abastado, F. Mammano, and O. Schwartz. 2005. Covert human immunodeficiency virus replication in dendritic cells and in DC-SIGN-expressing cells promotes long-term transmission to lymphocytes. J. Virol. 79: 5386-5399.
21. Turville, S. G., P. U. Cameron, A. Handley, G. Lin, S. Pohlmann, R. W. Doms, and A. L. Cunningham. 2002. Diversity of receptors binding HIV on dendritic cell subsets. Nat. Immunol. 3: 975-983.
22. Geijtenbeek, T. B., D. S. Kwon, R. Torensma, S. J. van Vliet, G. C. van Duijnhoven, J. Middel, I. L. Cornelissen, H. S. Nottet, V. N. KewalRamani, D. R. Littman, et al. 2000. DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells. Cell 100: 587-597.
23. Zhu, T., B. T. Korber, A. J. Nahmias, E. Hooper, P. M. Sharp, and D. D. Ho. 1998. An African HIV-1 sequence from 1959 and implications for the origin of the epidemic. Nature 391: 594-597.
24. Saiki, R. K., C. A. Chang, C. H. Levenson, T. C. Warren, C. D. Boehm, H. H. Kazazian, Jr., and H. A. Erlich. 1988. Diagnosis of sickle cell anemia and β-thalassemia with enzymatically amplified DNA and nonradioactive allele-specific oligonucleotide probes. N. Engl. J. Med. 319: 537-541.
25. Dierich, M. P., C. F. Ebenbichler, P. Marschang, G. Fust, N. M. Thielens, and G. J. Arlaud. 1993. HIV and human complement: mechanisms of interaction and biological implication. Immunol. Today 14: 435-440.
26. Susal, C., M. Kirschfink, M. Kropelin, V. Daniel, and G. Opelz. 1994. Complement activation by recombinant HIV-1 glycoprotein gp120. J. Immunol. 152: 6028-6034.
27. Saifuddin, M., C. J. Parker, M. E. Peeples, M. K. Gorny, S. Zolla-Pazner, M. Ghassemi, I. A. Rooney, J. P. Atkinson, and G. T. Spear. 1995. Role of virion-associated glycosylphosphatidylinositol-linked proteins CD55 and CD59 in complement resistance of cell line-derived and primary isolates of HIV-1. J. Exp. Med. 182: 501-509.
28. Quinkal, I., J. F. Hernandez, S. Chevallier, G. J. Arlaud, and T. Vernet. 1999. Mapping of the interaction between the immunodominant loop of the ectodomain of HIV-1 gp41 and human complement protein Clq. Eur. J. Biochem. 265: 656-663.
29. Saifuddin, M., T. Hedayati, J. P. Atkinson, M. H. Holguin, C. J. Parker, and G. T. Spear. 1997. Human immunodeficiency virus type 1 incorporates both glycosyl phosphatidylinositol-anchored CD55 and CD59 and integral membrane CD46 at levels that protect from complement-mediated destruction. J. Gen. Virol. 78: 1907-1911.
30. Doepper, S., L. Kacani, B. Falkensammer, M. P. Dierich, and H. Stoiber. 2002. Complement receptors in HIV infection. Curr. Mol. Med. 2: 703-711.
31. Tregoat, V., P. Montagne, M. L. Cuilliere, M. C. Bene, and G. Faure. 1999. C3/C4 concentration ratio reverses between colostrum and mature milk in human lactation. J. Clin. Immunol. 19: 300-304.
32. Joling, P., L. J. Bakker, J. A. Van Strijp, T. Meerloo, L. de Graaf, M. E. Dekker, J. Goudsmit, J. Verhoef, and H. J. Schuurman. 1993. Binding of human immunodeficiency virus type-1 to follicular dendritic cells in vitro is complement dependent. J. Immunol. 150: 1065-1073.
33. Stoiber, H., C. Speth, and M. P. Dierich. 2003. Role of complement in the control of HIV dynamics and pathogenesis. Vaccine 21: S77-S82.
34. Kacani, L., W. M. Prodinger, G. M. Sprinzl, M. G. Schwendinger, M. Spruth, H. Stoiber, S. Dopper, S. Steinhuber, F. Steindl, and M. P. Dierich. 2000. Detachment of human immunodeficiency virus type 1 from germinal centers by blocking complement receptor type 2. J. Virol. 74: 7997-8002.
35. Hioe, C. E., M. Tuen, P. C. Chien, Jr., G. Jones, S. Ratto-Kim, P. J. Norris, W. J. Moretto, D. F. Nixon, M. K. Gorny, and S. Zolla-Pazner. 2001. Inhibition of human immunodeficiency virus type 1 gp120 presentation to CD4 T cells by antibodies specific for the CD4 binding domain of gp120. J. Virol. 75: 10950-10957.
36. Jameson, B., F. Baribaud, S. Pohlmann, D. Ghavimi, F. Mortari, R. W. Doms, and A. Iwasaki. 2002. Expression of DC-SIGN by dendritic cells of intestinal and genital mucosae in humans and rhesus macaques. J. Virol. 76: 1866-1875.
37. Pellis, V., F. De Seta, S. Crovella, F. Bossi, R. Bulla, S. Guaschino, O. Radillo, P. Garred, and F. Tedesco. 2005. Mannose binding lectin and C3 act as recognition molecules for infectious agents in the vagina. Clin. Exp. Immunol. 139: 120-126.